Larotrectinib - CaLiGraph

CaLiGraph

Property	Value
rdf:type	Receptor tyrosine kinase inhibitor owl:NamedIndividual Orphan drug Bayer brand Tissue agnostic antineoplastic agent Drug granted breakthrough therapy designation
rdfs:label	Larotrectinib
owl:sameAs	dbr:Larotrectinib
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:Bayer_brands http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Category:Tissue_agnostic_antineoplastic_agents http://en.wikipedia.org/wiki/Category:Receptor_tyrosine_kinase_inhibitors
skos:prefLabel	Larotrectinib
skos:altLabel	LOXO-101 larotrectinib
clgo:alternativeName	Vitrakvi
clgo:casNumber	1223403-58-4
clgo:chEMBL	3889654
clgo:drugbank	DB14723
clgo:fdaUniiCode	PF9462I9HX
clgo:kegg	D11137 D11138
clgo:medlinePlus	a619006
clgo:pubchem	46188928

About: clgr:Larotrectinib